• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】56942

【品名】(4S,6R)-2-methoxy-6-[(1S)-1-methyl-3-butenyl]tetrahydro-2H-pyran-4-ol

【CA登记号】

【 分 子 式 】C11H20O3

【 分 子 量 】200.278

【元素组成】C 65.97% H 10.07% O 23.97%

与该中间体有关的原料药合成路线共 2 条

合成路线1

该中间体在本合成路线中的序号:(XI)

The chiral tetrahydropyran intermediate (XI) has been obtained as follows. The reaction of (-)-pseudoephedrine propionamide (I) with the allyl bromide (II) by the Myers' method gives pentenamide (III), which is reduced with LiNH2BH3 in THF to yield 2(S)-methyl-4-penten-1-ol (IV). Swern oxidation of (IV) affords the corresponding aldehyde (V), which is submitted to an asymmetric aldol condensation with the silyl enol ether (VI) catalyzed by Cu(OTf)2, (S)-Tol-BINAP and (Bu4N)Ph3SiF2 in THF to provide the adduct (VII). The methanolysis of (VII) with Me-OH in refluxing toluene gives the beta-keto ester (VIII), which is treated with Et2BOMe, NaBH4 and HF to yield the chiral hydroxy lactone (IX). The reduction of (IX) with DIBAL in THF affords the lactol (X), which is finally methylated with Ts-OH in refluxing methanol to provide the target tetrahydropyran intermediate (XI).

1 Bauer, M.; Maier, M.E.; Synthesis of the core structure of salicylihalamide A by intramolecular Suzuki reaction. Org Lett 2002, 4, 13, 2205.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 56935 N-[(1R,2R)-2-hydroxy-1-methyl-2-phenylethyl]-N-methylpropanamide C13H19NO2 详情 详情
(II) 11463 3-Bromo-1-propene; 3-Bromopropene;allyl bromide 106-95-6 C3H5Br 详情 详情
(III) 56936 (2S)-N-[(1R,2R)-2-hydroxy-1-methyl-2-phenylethyl]-N,2-dimethyl-4-pentenamide C16H23NO2 详情 详情
(IV) 56937 (2S)-2-methyl-4-penten-1-ol C6H12O 详情 详情
(V) 26241 (2S)-2-methyl-4-pentenal C6H10O 详情 详情
(VI) 53651 [(2,2-dimethyl-4-methylene-4H-1,3-dioxin-6-yl)oxy](trimethyl)silane; 2,2-dimethyl-4-methylene-4H-1,3-dioxin-6-yl trimethylsilyl ether n/a C10H18O3Si 详情 详情
(VII) 56938 6-[(2R,3S)-2-hydroxy-3-methyl-5-hexenyl]-2,2-dimethyl-4H-1,3-dioxin-4-one C13H20O4 详情 详情
(VIII) 56939 methyl (5R,6S)-5-hydroxy-6-methyl-3-oxo-8-nonenoate C11H18O4 详情 详情
(IX) 56940 (4S,6R)-4-hydroxy-6-[(1S)-1-methyl-3-butenyl]tetrahydro-2H-pyran-2-one C10H16O3 详情 详情
(X) 56941 (4S,6R)-6-[(1S)-1-methyl-3-butenyl]tetrahydro-2H-pyran-2,4-diol C10H18O3 详情 详情
(XI) 56942 (4S,6R)-2-methoxy-6-[(1S)-1-methyl-3-butenyl]tetrahydro-2H-pyran-4-ol C11H20O3 详情 详情

合成路线2

该中间体在本合成路线中的序号:(XI)

The Stille coupling of the benzodioxanone (XII) with allyltributyltin (XIII) by means of trifurylphosphine (TFP) and Pd2(dba)3 gives the 6-allylsalicylic acid (XIV), which is esterified with the intermediate (XI) by means of DEAD and PPH3 in ethyl ether to yield the ester (XV). Hydrolysis of the lactol group of (XV) with Ac-OH affords the carbaldehyde (XVI), which is condensed with the phosphorane (XVII) to provide the unsaturated ester (XVIII). The silylation of the free OH groups of (XVIII) with Tbdms-OTf and lutidine gives the protected compound (XIX), which is submitted to a rig closing metathesis reaction catalyzed by a Ru catalyst in dichloromethane to yield the macrolactone (XX). The selective hydrolysis of the methyl ester group of (XX) by treatment with (Bu3Sn)2O in refluxing toluene affords the unsaturated carboxylic acid (XXI), which is treated with DPPA in refluxing benzene to provide the corresponding isocyanate (XXII). The reaction of the isocyanate group of (XXII) with (1Z,3Z)-hexadienyl cuprate, prepared in situ by reaction of Et-Li, CuBr/Me2S and acetylene, gives the silylated heptadienamide (XXIII), along with some pentanamide and nonatrienamide derivatives that are separated by chromatography. Finally, compound (XXIII) is desilylated by means of HF and pyridine in THF to provide the target salicylhalamide A.

1 Bauer, M.; Maier, M.E.; Synthesis of the core structure of salicylihalamide A by intramolecular Suzuki reaction. Org Lett 2002, 4, 13, 2205.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XI) 56942 (4S,6R)-2-methoxy-6-[(1S)-1-methyl-3-butenyl]tetrahydro-2H-pyran-4-ol C11H20O3 详情 详情
(XII) 56943 2,2-dimethyl-4-oxo-4H-1,3-benzodioxin-5-yl trifluoromethanesulfonate C11H9F3O6S 详情 详情
(XIII) 40599 Allyltributyltin; Tributyl-2-propenylstannane 24850-33-7 C15H32Sn 详情 详情
(XIV) 56944 2-allyl-6-hydroxybenzoic acid C10H10O3 详情 详情
(XV) 56945 (4R,6R)-2-methoxy-6-[(1S)-1-methyl-3-butenyl]tetrahydro-2H-pyran-4-yl 2-allyl-6-hydroxybenzoate C21H28O5 详情 详情
(XVI) 56946 (1R,3R,4S)-3-hydroxy-4-methyl-1-(2-oxoethyl)-6-heptenyl 2-allyl-6-hydroxybenzoate C20H26O5 详情 详情
(XVII) 14689 Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate 2605-67-6 C21H19O2P 详情 详情
(XVIII) 56947 (1S,3R,4S)-3-hydroxy-1-[(E)-4-methoxy-4-oxo-2-butenyl]-4-methyl-6-heptenyl 2-allyl-6-hydroxybenzoate C23H30O6 详情 详情
(XIX) 56948 (1S,3R,4S)-3-{[tert-butyl(dimethyl)silyl]oxy}-1-[(E)-4-methoxy-4-oxo-2-butenyl]-4-methyl-6-heptenyl 2-allyl-6-{[tert-butyl(dimethyl)silyl]oxy}benzoate C35H58O6Si2 详情 详情
(XX) 56949 methyl (E)-4-((3S,5R,6S)-5,14-bis{[tert-butyl(dimethyl)silyl]oxy}-6-methyl-1-oxo-3,4,5,6,7,10-hexahydro-1H-2-benzoxacyclododecin-3-yl)-2-butenoate C33H54O6Si2 详情 详情
(XXI) 56950 (E)-4-((3S,5R,6S)-5,14-bis{[tert-butyl(dimethyl)silyl]oxy}-6-methyl-1-oxo-3,4,5,6,7,10-hexahydro-1H-2-benzoxacyclododecin-3-yl)-2-butenoic acid C32H52O6Si2 详情 详情
(XXII) 56951 (3S,5R,6S)-5,14-bis{[tert-butyl(dimethyl)silyl]oxy}-3-[(E)-3-isocyanato-2-propenyl]-6-methyl-3,4,5,6,7,10-hexahydro-1H-2-benzoxacyclododecin-1-one C32H51NO5Si2 详情 详情
(XXIII) 56952 (2Z,4Z)-N-[(E)-3-((3S,5R,6S)-5,14-bis{[tert-butyl(dimethyl)silyl]oxy}-6-methyl-1-oxo-3,4,5,6,7,10-hexahydro-1H-2-benzoxacyclododecin-3-yl)-1-propenyl]-2,4-heptadienamide C38H61NO5Si2 详情 详情
Extended Information